21 May 2009
Low incidence of hepatic artery thrombosis after hepatic artery reconstruction in liver transplanation
O Kornasiewicz, Z Lewandowski, M Grąt, A Ścibisz, M KrawczykAnn Transplant 2009; 14(1): 43-43 :: ID: 880356
Abstract
Background: Hepatic artery thrombosis (HAT) remains an important cause
of graft loss after liver transplantation. HAT can be caused by technical, hemodynamic, or immunological factors. Bench reconstruction of anatomical variants of the hepatic artery is considered to be a major risk related to HAT. The purposes of the study were to analyse the infl uence of vascular reconstruction of the hepatic artery and its relation to HAT.
Material/Methods: We analysed, in retrospective study, 341 donors' forms
completed between January 2003 and December 2007. Vascular reconstruction was defined as an additional anastomosis between the donor's hepatic arteries which was required to obtain a full revascularisation of the graft. Any incident of HAT was confi rmed by angiography or intraoperatively during re-transplanation. The Fishers Exact Test and 95% confidence intervals (CI) estimator were applied for statistical analysis.
Results: Of 341 grafts, hepatic artery anomalies were found in 92 cases
(26.9%). In 33 (35.8%) cases hepatic artery reconstruction was required. The HAT was diagnosed in 3% (1 of 33) with hepatic reconstruction group (CI 0.1%-15.8%) compared with 1.6% of grafts (5 of 208) which did not require hepatic reconstruction (p<0.45). There was one case of hepatic thrombosis (1 of 59) totalling 1.6% in the group with hepatic anomalies without reconstruction (CI 0.04-9.1%)
Conclusions: A single hepatic reconstruction is a non significant factor for HAT. The hepatic artery anomalies do not increase the risk of HAT compared with the normal blood supply. The hepatic artery anomalies do not increase significantly the incidence of HAT compared to group of patient without anatomical abnormalities.
Keywords: Liver Transplantation
Most Viewed Current Articles
26 Jan 2022 : Review article
Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive ModelsDOI :10.12659/AOT.934924
Ann Transplant 2022; 27:e934924
24 Aug 2021 : Review article
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
29 Dec 2021 : Original article
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860